A single-nucleotide polymorphism in SCN9A may decrease postoperative pain sensitivity in the general population

Area of Science:

• Genetics
• Pain Research
• Pharmacogenomics

Background:

• Congenital indifference to pain is linked to SCN9A gene variations.
• A specific SCN9A polymorphism (3312G>T) is found in both pain-insensitive individuals and healthy controls.
• The predictive role of this polymorphism in general population pain perception is unclear.

Purpose of the Study:

• To investigate the predictive value of the SCN9A 3312G>T polymorphism for baseline pain perception.
• To assess the impact of this SCN9A variant on postoperative pain sensitivity and analgesic requirements.
• To determine if the 3312G>T allele influences the incidence of inadequate analgesia after surgery.

Main Methods:

• 200 patients undergoing pancreatectomy had preoperative pain thresholds and tolerance measured.
• Postoperative pain sensitivity and patient-controlled analgesia (PCA) demand were recorded.
• SCN9A 3312G>T allele status was analyzed, and logistic regression identified predictors of inadequate analgesia.

Main Results:

• The 3312T allele was present in 5.5% of patients.
• Patients with the 3312T allele showed significantly lower PCA pressing frequency and opioid consumption compared to 3312G allele carriers.
• The incidence of inadequate analgesia was substantially lower in 3312T allele carriers (4.5% vs. 29.2%).

Conclusions:

• The SCN9A 3312T allele is associated with reduced postoperative pain sensitivity.
• Carrying the 3312T allele significantly lowers the likelihood of experiencing inadequate analgesia.
• This genetic variant may serve as a biomarker for predicting pain response and optimizing analgesia strategies.